IP receptor — Drug Target

All drugs that target IP receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

prostacyclin receptor agonist · Prostacyclin analog

Phase 3 pipeline (2)

• i.v. selexipag · Actelion · prostacyclin receptor agonist · Cardiovascular
  Selexipag is a prostacyclin receptor agonist that acts as a potent vasodilator.
• selexipag (Uptravi) · Actelion · prostacyclin receptor agonist · Cardiovascular
  Selexipag is a prostacyclin receptor agonist that acts as a selective IP receptor agonist.

Phase 2 pipeline (1)

• Beraprost Sodium Modified Release · Lung Biotechnology PBC · Prostacyclin analog · Cardiovascular
  Beraprost sodium is a prostacyclin analog that acts on the IP receptor to dilate blood vessels and inhibit platelet aggregation.